Emyria Ltd capitalises on Cann Group Ltd collaboration to progress EMD-003 CBD medicine for mental health
Deep Dive - Emyria Ltd
Source: proactiveinvestors.com.au
Emyria Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Emyria Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Emyria Data Today - Breaking & Trending Today
Emyria Ltd begins recruiting for EMD-RX5 Phase 1 clinical safety and bioavailability study
Emyria Ltd (ASX:EMD) has started participant recruitment, screening and consenting for its Phase 1 clinical trial of EMD-RX5, with dosing expected to begin...
Source: proactiveinvestors.com.au
Emyria Ltd enhances growth strategy with appointment of Sixty Two Capital as corporate advisor
“Sixty Two Capital has a track record of supporting high growth client companies over the long-term,” says MD.
Source: proactiveinvestors.com.au
Emyria Ltd's ultra-pure CBD capsule outperforms TGA-approved CBD treatment in pre-clinical animal trial
“These animal study results suggest Emyria has developed a novel, high performing and cost-effective CBD capsule that can meet the strict...
Source: proactiveinvestors.com.au
Emyria Ltd passes MDMA analogue development milestone with Eurofins to lead extensive compound screening program
“We are pleased to be working with global leader Eurofins to screen our first batch of novel MDMA-analogues after successfully completing...
Source: proactiveinvestors.com.au